Balance Sheet Exelixis, Inc.

Equities

EXEL

US30161Q1040

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:30:00 15/01/2026 am IST			5-day change	1st Jan Change
45.23 ^USD	+2.61%		+3.55%	+3.19%

14/01	Truist Securities Adjusts Price Target on Exelixis to $51 From $49, Maintains Buy Rating	MT
13/01	Exelixis, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 05:15 PM

21d0869277b6.a4YM1VCbU97sEDeyT1fNJqTe8A2Xfdmqms45wrUjzl0.JcNinGnNJKyJY1LQOy29dfOznDvWF7CH9Yt-kcJyoi8b7VWwIeM7p6UiAw

Published financial data: EXELIXIS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	99Cr	143.5Cr	161.11Cr	183.02Cr	216.87Cr
Total Revenues	99Cr	143.5Cr	161.11Cr	183.02Cr	216.87Cr
Cost of Goods Sold, Total	3.36Cr	5.29Cr	5.79Cr	7.25Cr	7.62Cr
Gross Profit	95Cr	138.21Cr	155.32Cr	175.77Cr	209.25Cr
Selling General & Admin Expenses, Total	29Cr	40Cr	46Cr	54Cr	49Cr
R&D Expenses	55Cr	69Cr	89Cr	104.41Cr	91Cr
Other Operating Expenses, Total	84Cr	109.54Cr	135.17Cr	158.68Cr	140.25Cr
Operating Income	11Cr	29Cr	20Cr	17Cr	69Cr
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	1.99Cr	76.72L	3.31Cr	8.65Cr	7.72Cr
Net Interest Expenses	1.99Cr	76.72L	3.31Cr	8.65Cr	7.72Cr
Currency Exchange Gains (Loss)	9L	8L	12L	-	-
Other Non Operating Income (Expenses)	12T	-10L	-13.97L	93T	-1L
EBT, Excl. Unusual Items	13Cr	29Cr	23Cr	26Cr	77Cr
Restructuring Charges	-	-	-	-	-3.37Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-27L	-	-	-	-5.17Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	13Cr	29Cr	23Cr	26Cr	68Cr
Income Tax Expense	1.91Cr	6.31Cr	5.21Cr	4.98Cr	16Cr
Earnings From Continuing Operations	11Cr	23Cr	18Cr	21Cr	52Cr
Net Income to Company	11Cr	23Cr	18Cr	21Cr	52Cr
Net Income - (IS)	11Cr	23Cr	18Cr	21Cr	52Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	11Cr	23Cr	18Cr	21Cr	52Cr
Net Income to Common Excl. Extra Items	11Cr	23Cr	18Cr	21Cr	52Cr
Per Share Items
Net EPS - Basic	0.36	0.73	0.57	0.65	1.8
Basic EPS - Continuing Operations	0.36	0.73	0.57	0.65	1.8
Basic Weighted Average Shares Outstanding	31Cr	31Cr	32Cr	32Cr	29Cr
Net EPS - Diluted	0.35	0.72	0.56	0.65	1.76
Diluted EPS - Continuing Operations	0.35	0.72	0.56	0.65	1.76
Diluted Weighted Average Shares Outstanding	32Cr	32Cr	32Cr	32Cr	30Cr
Normalized Basic EPS	0.27	0.58	0.46	0.51	1.65
Normalized Diluted EPS	0.26	0.57	0.45	0.5	1.62
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	12Cr	30Cr	22Cr	20Cr	72Cr
EBITA	11Cr	29Cr	20Cr	17Cr	69Cr
EBIT	11Cr	29Cr	20Cr	17Cr	69Cr
EBITDAR	13Cr	31Cr	24Cr	23Cr	76Cr
Total Revenues (As Reported)	99Cr	143.5Cr	161.11Cr	183.02Cr	216.87Cr
Effective Tax Rate - (Ratio)	14.56	21.45	22.22	19.32	23.53
Current Domestic Taxes	37.91L	1.66Cr	11Cr	18Cr	22Cr
Total Current Taxes	37.91L	1.66Cr	11Cr	18Cr	22Cr
Deferred Domestic Taxes	1.53Cr	4.65Cr	-6.04Cr	-13Cr	-5.95Cr
Total Deferred Taxes	1.53Cr	4.65Cr	-6.04Cr	-13Cr	-5.95Cr
Normalized Net Income	8.35Cr	18Cr	15Cr	16Cr	48Cr
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	2.51Cr	3.18Cr	4.16Cr	4Cr	4.35Cr
Selling and Marketing Expenses	2.51Cr	3.18Cr	4.16Cr	4Cr	4.35Cr
Research And Development Expense From Footnotes	55Cr	69Cr	89Cr	104.41Cr	91Cr
Net Rental Expense, Total	76.55L	80.17L	2.14Cr	3.6Cr	3.67Cr
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	3.72Cr	4.67Cr	4.54Cr	3.43Cr	3.07Cr
Stock-Based Comp., SG&A Exp. (Total)	6.79Cr	7.32Cr	6.22Cr	7.2Cr	6.32Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	11Cr	12Cr	11Cr	11Cr	9.38Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	32Cr	65Cr	50Cr	26Cr	22Cr
Short Term Investments	89Cr	82Cr	81Cr	73Cr	89Cr
Total Cash And Short Term Investments	120.65Cr	146.71Cr	130.85Cr	100Cr	111.13Cr
Accounts Receivable, Total	16Cr	28Cr	21Cr	24Cr	27Cr
Other Receivables	45L	29L	73L	1.31Cr	1.49Cr
Total Receivables	17Cr	29Cr	22Cr	25Cr	28Cr
Inventory	2.1Cr	2.75Cr	3.33Cr	1.73Cr	2.24Cr
Prepaid Expenses	5.25Cr	4.48Cr	5.13Cr	5.48Cr	5.36Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	98L	36L	-	-
Total Current Assets	144.54Cr	183.47Cr	161.88Cr	131.8Cr	146.76Cr
Gross Property Plant And Equipment	15Cr	19Cr	41Cr	44Cr	39Cr
Accumulated Depreciation	-3.47Cr	-4.08Cr	-6.09Cr	-8.04Cr	-10Cr
Net Property Plant And Equipment	11Cr	15Cr	35Cr	36Cr	29Cr
Long-term Investments	33Cr	37Cr	76Cr	73Cr	64Cr
Goodwill	6.37Cr	6.37Cr	6.37Cr	6.37Cr	6.37Cr
Accounts Receivable Long-Term	-	16.65L	16.59L	13.21L	4L
Deferred Tax Assets Long-Term	16Cr	11Cr	23Cr	36Cr	42Cr
Other Long-Term Assets, Total	3.04Cr	8.42Cr	5.41Cr	11Cr	6.68Cr
Total Assets	213.73Cr	261.62Cr	307.15Cr	294.24Cr	294.77Cr
Liabilities
Accounts Payable, Total	2.36Cr	2.43Cr	3.27Cr	3.38Cr	3.82Cr
Accrued Expenses, Total	14Cr	26Cr	21Cr	25Cr	30Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	30.25L	51.37L	1.77Cr	2.57Cr	2.5Cr
Unearned Revenue Current, Total	17.9L	78.14L	74.88L	54.06L	27.39L
Other Current Liabilities	3.96Cr	4.04Cr	5.38Cr	7.73Cr	4.11Cr
Total Current Liabilities	20Cr	34Cr	32Cr	39Cr	40Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	4.91Cr	5.13Cr	19Cr	19Cr	19Cr
Unearned Revenue Non Current	37.55L	87.39L	65.82L	55.24L	33.92L
Other Non Current Liabilities	7L	80.23L	6.2Cr	8.87Cr	11Cr
Total Liabilities	26Cr	41Cr	58Cr	68Cr	70Cr
Common Stock, Total	3L	3L	3L	3L	3L
Additional Paid In Capital	232.19Cr	242.76Cr	253.68Cr	244.07Cr	234.39Cr
Retained Earnings	-45Cr	-22Cr	-3.42Cr	-17Cr	-9.86Cr
Comprehensive Income and Other	44.76L	-8L	-1.45Cr	-37.5L	-13.47L
Total Common Equity	187.91Cr	221.06Cr	248.84Cr	226.39Cr	224.42Cr
Total Equity	187.91Cr	221.06Cr	248.84Cr	226.39Cr	224.42Cr
Total Liabilities And Equity	213.73Cr	261.62Cr	307.15Cr	294.24Cr	294.77Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	31Cr	32Cr	32Cr	30Cr	28Cr
ECS Total Common Shares Outstanding	31Cr	32Cr	32Cr	30Cr	28Cr
Book Value / Share	6.03	6.93	7.68	7.48	7.97
Tangible Book Value	181.54Cr	214.69Cr	242.47Cr	220.02Cr	218.05Cr
Tangible Book Value Per Share	5.83	6.73	7.48	7.27	7.74
Total Debt	5.21Cr	5.64Cr	21Cr	22Cr	22Cr
Net Debt	-115.44Cr	-141.07Cr	-110.06Cr	-78Cr	-153.27Cr
Debt Equivalent Oper. Leases	6.12Cr	6.41Cr	17Cr	29Cr	29Cr
Account Code - Inventory Valuation	3	3	3	3	5
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	-	-	-	-	-
Machinery, Total	4.5Cr	5.44Cr	8.32Cr	9.56Cr	11Cr
Full Time Employees	773	954	1.22T	1.31T	1.15T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	11Cr	23Cr	18Cr	21Cr	52Cr
Depreciation & Amortization - CF	91.41L	1.36Cr	2.09Cr	2.57Cr	2.88Cr
Depreciation & Amortization, Total	91.41L	1.36Cr	2.09Cr	2.57Cr	2.88Cr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	11Cr	13Cr	12Cr
Stock-Based Compensation (CF)	11Cr	12Cr	11Cr	11Cr	9.38Cr
Other Operating Activities, Total	2.31Cr	7.53Cr	-4.26Cr	-12Cr	-4.56Cr
Change In Accounts Receivable	-4.25Cr	-12Cr	6.68Cr	-2.26Cr	-2.8Cr
Change In Inventories	-2.19Cr	-1.32Cr	-1.17Cr	-1.3Cr	54.53L
Change In Accounts Payable	5.11Cr	5.51Cr	2.58Cr	5.32Cr	-2.19Cr
Change in Unearned Revenues	-10.51L	1.1Cr	-24.83L	-31.4L	-
Change in Other Net Operating Assets	-2.58Cr	3.04Cr	-9.13Cr	-2.85Cr	3.09Cr
Cash from Operations	21Cr	40Cr	36Cr	33Cr	70Cr
Capital Expenditure	-3.03Cr	-6.42Cr	-2.77Cr	-4.05Cr	-2.84Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-11Cr	-12Cr	-3.78Cr
Investment in Marketable and Equity Securities, Total	-10Cr	2.13Cr	-39Cr	14Cr	-5.06Cr
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-13Cr	-4.29Cr	-52Cr	-2.7Cr	-12Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	2.49Cr	2.43Cr	2.39Cr	3.34Cr	6.18Cr
Repurchase of Common Stock	-5Cr	-3.91Cr	-2.33Cr	-58Cr	-69Cr
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-2.51Cr	-1.48Cr	6L	-55Cr	-63Cr
Net Change in Cash	5.26Cr	34Cr	-16Cr	-24Cr	-4.56Cr
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	41.15L	1.3Cr	13Cr	19Cr	17Cr
Levered Free Cash Flow	14Cr	25Cr	15Cr	13Cr	46Cr
Unlevered Free Cash Flow	14Cr	25Cr	15Cr	13Cr	46Cr
Change In Net Working Capital	1.83Cr	-20.06L	-3.16Cr	-4.95Cr	2.35Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.5	7.54	4.43	3.55	14.64
Return on Total Capital	3.84	8.54	5.07	4.13	17.46
Return On Equity %	6.27	11.3	7.76	8.74	23.13
Return on Common Equity	6.27	11.3	7.76	8.74	23.13
Margin Analysis
Gross Profit Margin %	96.6	96.32	96.41	96.04	96.49
SG&A Margin	29.71	27.99	28.54	29.65	22.69
EBITDA Margin %	12.34	20.93	13.8	10.74	33.14
EBITA Margin %	11.42	19.98	12.51	9.34	31.81
EBIT Margin %	11.42	19.98	12.51	9.34	31.81
Income From Continuing Operations Margin %	11.32	16.1	11.31	11.35	24.04
Net Income Margin %	11.32	16.1	11.31	11.35	24.04
Net Avail. For Common Margin %	11.32	16.1	11.31	11.35	24.04
Normalized Net Income Margin	8.45	12.81	9.09	8.79	22.1
Levered Free Cash Flow Margin	13.78	17.45	9.16	6.85	21.41
Unlevered Free Cash Flow Margin	13.78	17.45	9.16	6.85	21.41
Asset Turnover
Asset Turnover	0.49	0.6	0.57	0.61	0.74
Fixed Assets Turnover	9.82	11.06	6.51	5.17	6.63
Receivables Turnover (Average Receivables)	7.03	6.47	6.48	8.09	8.63
Inventory Turnover (Average Inventory)	1.98	2.18	1.91	2.87	3.84
Short Term Liquidity
Current Ratio	7.06	5.43	4.99	3.34	3.63
Quick Ratio	6.7	5.19	4.72	3.16	3.45
Operating Cash Flow to Current Liabilities	1.02	1.19	1.12	0.85	1.73
Days Sales Outstanding (Average Receivables)	52.07	56.41	56.35	45.09	42.43
Days Outstanding Inventory (Average Inventory)	184.56	167.29	191.59	127.35	95.35
Average Days Payable Outstanding	154.68	147.15	163.05	214.32	162.01
Cash Conversion Cycle (Average Days)	81.95	76.54	84.88	-41.89	-24.23
Long Term Solvency
Total Debt/Equity	2.77	2.55	8.35	9.53	9.62
Total Debt / Total Capital	2.7	2.49	7.71	8.7	8.77
LT Debt/Equity	2.61	2.32	7.64	8.39	8.5
Long-Term Debt / Total Capital	2.54	2.26	7.05	7.66	7.76
Total Liabilities / Total Assets	12.08	15.5	18.98	23.06	23.87
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.4	0.18	0.85	0.93	0.29
Net Debt / EBITDA	-8.91	-4.58	-4.52	-3.35	-2.03
Total Debt / (EBITDA - Capex)	0.53	0.23	0.96	1.12	0.3
Net Debt / (EBITDA - Capex)	-11.64	-5.78	-5.09	-4.06	-2.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.04	45.31	12.27	13.6	18.49
Gross Profit, 1 Yr. Growth %	1.92	45.29	12.38	13.17	19.05
EBITDA, 1 Yr. Growth %	-67.85	151.92	-25.95	-11.58	265.59
EBITA, 1 Yr. Growth %	-69.59	160.46	-29.71	-15.19	303.75
EBIT, 1 Yr. Growth %	-69.59	160.46	-29.71	-15.19	303.75
Earnings From Cont. Operations, 1 Yr. Growth %	-65.18	106.71	-21.11	13.98	150.89
Net Income, 1 Yr. Growth %	-65.18	106.71	-21.11	13.98	150.89
Normalized Net Income, 1 Yr. Growth %	-66.57	124.82	-20.33	9.89	197.83
Diluted EPS Before Extra, 1 Yr. Growth %	-65.69	105.71	-22.22	16.07	170.77
Accounts Receivable, 1 Yr. Growth %	33.91	75.7	-24.01	10.53	11.81
Inventory, 1 Yr. Growth %	62.76	31.09	21.12	-47.98	29.24
Net Property, Plant and Equip., 1 Yr. Growth %	21.68	35.11	131.6	4.79	-19.34
Total Assets, 1 Yr. Growth %	13.35	22.41	17.4	-4.2	0.18
Tangible Book Value, 1 Yr. Growth %	11.91	18.26	12.94	-9.26	-0.9
Common Equity, 1 Yr. Growth %	11.46	17.64	12.57	-9.02	-0.87
Cash From Operations, 1 Yr. Growth %	-60.34	91.79	-9.53	-8.08	110
Capital Expenditures, 1 Yr. Growth %	136.44	111.65	-48.91	46.07	-29.74
Levered Free Cash Flow, 1 Yr. Growth %	-63.28	86.37	-41.08	-15.01	270.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-63.28	86.37	-41.08	-15.01	270.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.55	21.77	27.73	12.94	16.02
Gross Profit, 2 Yr. CAGR %	7.3	21.6	27.78	12.77	16.07
EBITDA, 2 Yr. CAGR %	-47.65	-10.85	36.58	-19.09	79.79
EBITA, 2 Yr. CAGR %	-49.37	-11.92	35.3	-22.79	85.05
EBIT, 2 Yr. CAGR %	-49.37	-11.92	35.3	-22.79	85.05
Earnings From Cont. Operations, 2 Yr. CAGR %	-59.75	-15.16	27.7	-5.18	69.11
Net Income, 2 Yr. CAGR %	-59.75	-15.16	27.7	-5.18	69.11
Normalized Net Income, 2 Yr. CAGR %	-45.72	-14.04	33.83	-6.43	80.91
Diluted EPS Before Extra, 2 Yr. CAGR %	-60.2	-15.98	26.49	-4.99	77.28
Accounts Receivable, 2 Yr. CAGR %	-0.58	53.39	15.55	-8.35	11.17
Inventory, 2 Yr. CAGR %	46.01	46.07	26	-20.62	-18
Net Property, Plant and Equip., 2 Yr. CAGR %	39.46	28.22	76.89	55.78	-8.07
Total Assets, 2 Yr. CAGR %	22.59	17.79	19.88	6.05	-2.04
Tangible Book Value, 2 Yr. CAGR %	21.8	15.04	15.57	1.23	-5.17
Common Equity, 2 Yr. CAGR %	20.81	14.51	15.08	1.2	-5.03
Cash From Operations, 2 Yr. CAGR %	-29.1	-12.79	31.72	-8.81	38.94
Capital Expenditures, 2 Yr. CAGR %	-4.54	123.7	-4.45	-13.61	1.31
Levered Free Cash Flow, 2 Yr. CAGR %	-11.74	-17.7	4.79	-29.23	77.38
Unlevered Free Cash Flow, 2 Yr. CAGR %	-11.74	-17.7	4.79	-29.23	77.38
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	29.71	18.89	18.52	22.83	14.76
Gross Profit, 3 Yr. CAGR %	29.56	18.6	18.45	22.71	14.83
EBITDA, 3 Yr. CAGR %	-10.19	-12.28	-16.2	18.15	33.77
EBITA, 3 Yr. CAGR %	-12.29	-13.31	-18.3	15.8	34.01
EBIT, 3 Yr. CAGR %	-12.29	-13.31	-18.3	15.8	34.01
Earnings From Cont. Operations, 3 Yr. CAGR %	-10.17	-30.56	-17.19	22.95	31.15
Net Income, 3 Yr. CAGR %	-10.17	-30.56	-17.19	22.95	31.15
Normalized Net Income, 3 Yr. CAGR %	-5.8	-13.42	-16.19	25.32	37.64
Diluted EPS Before Extra, 3 Yr. CAGR %	-10.8	-31.19	-18.12	22.92	34.71
Accounts Receivable, 3 Yr. CAGR %	27.67	20.2	21.37	13.85	-2.07
Inventory, 3 Yr. CAGR %	46.6	40.85	37.23	-6.17	-6.62
Net Property, Plant and Equip., 3 Yr. CAGR %	62.47	37.99	56.15	48.56	25.09
Total Assets, 3 Yr. CAGR %	48.3	22.53	17.66	11.24	4.06
Tangible Book Value, 3 Yr. CAGR %	101.69	20.61	14.34	6.62	0.52
Common Equity, 3 Yr. CAGR %	87.52	19.75	13.86	6.41	0.5
Cash From Operations, 3 Yr. CAGR %	8.06	-1.21	-11.71	16.84	20.42
Capital Expenditures, 3 Yr. CAGR %	12.8	24.48	29.24	10.07	-19.36
Levered Free Cash Flow, 3 Yr. CAGR %	13.8	12.76	-26.37	-2.27	22.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.66	12.76	-26.37	-2.27	22.85
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	92.69	49.61	28.91	16.47	17.51
Gross Profit, 5 Yr. CAGR %	94.27	49.45	28.77	16.23	17.49
EBITDA, 5 Yr. CAGR %	0.69	63.49	5.73	-15.07	13.73
EBITA, 5 Yr. CAGR %	-1.1	60.75	3.81	-17.23	13.3
EBIT, 5 Yr. CAGR %	-1.1	60.75	3.81	-17.23	13.3
Earnings From Cont. Operations, 5 Yr. CAGR %	-7.12	26.9	3.4	-21.34	10.18
Net Income, 5 Yr. CAGR %	-7.12	26.9	3.4	-21.34	10.18
Normalized Net Income, 5 Yr. CAGR %	-3.5	38.65	7.96	-10.69	14.01
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.66	20.77	2.57	-21.71	11.53
Accounts Receivable, 5 Yr. CAGR %	98.78	47.53	22.68	7.84	17.18
Inventory, 5 Yr. CAGR %	51.64	52.46	37.98	11.98	11.68
Net Property, Plant and Equip., 5 Yr. CAGR %	138.39	135.23	68.09	44.85	26.33
Total Assets, 5 Yr. CAGR %	45.1	34.44	36.2	15.65	9.35
Tangible Book Value, 5 Yr. CAGR %	54.76	142.44	61.42	12.45	6.09
Common Equity, 5 Yr. CAGR %	67.91	89.98	54.25	11.95	5.89
Cash From Operations, 5 Yr. CAGR %	8.18	13.76	16.97	-4.32	5.84
Capital Expenditures, 5 Yr. CAGR %	132.46	106.68	5.56	3.98	17.25
Levered Free Cash Flow, 5 Yr. CAGR %	14.56	73.65	9.84	-6.41	4.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.58	133.25	8.59	-6.41	4.66